Treace Medical (TMCI) grants officer 262,500 RSUs in equity award

Rhea-AI Filing Summary

Treace Medical Concepts Chief Legal & Compliance Officer Scot Michael Elder reported equity compensation and related share movements. On January 22, 2026, he disposed of 9,451 shares of Common Stock in a transaction coded "F" at a price of $0 per share, leaving him with 534,286 shares beneficially owned immediately after that line item. The same day, he acquired 262,500 shares of Common Stock in a transaction coded "A" at $0 per share, reported as restricted stock units.

The footnotes explain that these 262,500 RSUs each convert into one share of Common Stock upon vesting and vest in equal annual installments over four years, from January 22, 2027 through January 22, 2030, subject to continued service. After the reported transactions, Elder is shown as beneficially owning 796,786 shares, which includes 641,470 restricted stock units.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Elder Scot Michael

(Last) (First) (Middle)

C/O TREACE MEDICAL CONCEPTS, INC.

100 PALMETTO PARK PLACE

(Street)

PONTE VEDRA FL 32081

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
TREACE MEDICAL CONCEPTS, INC. [ TMCI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Legl & Comp Off, CorpSec

3. Date of Earliest Transaction (Month/Day/Year)
01/22/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/22/2026		F		9,451	D	$0	534,286(1)	D
Common Stock	01/22/2026		A		262,500(2)	A	$0	796,786(3)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Includes 378,970 restricted stock units.

2. Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs vest in equal annual installments over 4 years, with the first installment vesting on January 22, 2027 and the last installment vesting on January 22, 2030; subject to Reporting Person's providing continued service to Issuer through each vesting date.

3. Includes 641,470 restricted stock units.

	/s/ Lisa Taylor as Attorney-in-fact for Scot Elder	01/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider activity did TMCI officer Scot Michael Elder report on this Form 4?

Scot Michael Elder, Chief Legal & Compliance Officer and Corporate Secretary of Treace Medical Concepts, Inc. (TMCI), reported disposing of 9,451 shares of Common Stock in a transaction coded "F" and acquiring 262,500 shares of Common Stock in a transaction coded "A" on January 22, 2026.

How many Treace Medical (TMCI) shares does Scot Michael Elder beneficially own after the reported transactions?

Following the reported transactions, Scot Michael Elder is shown as beneficially owning 796,786 shares of Common Stock, which the footnotes state includes 641,470 restricted stock units.

What are the terms of the 262,500 restricted stock units granted to the TMCI officer?

The 262,500 restricted stock units (RSUs) entitle the reporting person to receive one share of Common Stock for each RSU upon vesting. According to the footnote, these RSUs vest in equal annual installments over 4 years, with the first installment vesting on January 22, 2027 and the last on January 22, 2030, subject to continued service.

What does the footnote say about restricted stock units held by the TMCI officer?

One footnote states that Elder's holdings include 378,970 restricted stock units, and another notes that after the grant, his total reported beneficial ownership includes 641,470 restricted stock units. These RSUs each convert into one share of Common Stock upon vesting.

What is the significance of transaction codes "F" and "A" in this TMCI Form 4?

In this filing, the transaction coded "F" shows a disposition of 9,451 shares of Common Stock at a price of $0 per share, and the transaction coded "A" reflects an acquisition of 262,500 shares of Common Stock, also at $0 per share, reported as restricted stock units. Both transactions occurred on January 22, 2026.

What is Scot Michael Elder’s role at Treace Medical Concepts (TMCI)?

The reporting person, Elder Scot Michael, is identified as an officer of Treace Medical Concepts, Inc., holding the title Chief Legal & Compliance Officer and Corporate Secretary.